GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors […]
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors […]
Foldax Appoints Scott Huennekens to Board of Directors […]
PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers. […]
Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”) […]
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities […]
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy […]
Premier Neurology Facility in Colorado Joins the CenExel Centers of Excellence […]
CenExel Clinical Research, Inc. announced the acquisition of California Neuroscience Research. […]
Nexus Spine announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing. […]
Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved populations with high disease burden […]
PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 /PRNewswire/ — BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder, today announced additions to its leadership team in preparation for commercialization of the RENOVA product line. The company has added Mike Ruger as Vice President of Sales, Sandra […]
National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes […]